Homeyahoo-finance2
MOONLAKE IMMUNOTHERAPEUTICS
Indicative price
$11.39
Nov 4, 2026
1
Funds holding
$3.3M
Reported value
167,768
Reported shares
Company profile
Stage
Country
Mark dateNov 4, 2026
Price history
Price per share in USD
Nov 4, 2026O $11.86H $11.93L $10.95C $11.39
Current funds holding MOONLAKE IMMUNOTHERAPEUTICS
| Fund | Manager | As of | Shares | Fair value | % of fund | AUM |
|---|---|---|---|---|---|---|
| T. Rowe Price Capital Appreciation Equity ETF TCAF | T. Rowe Price | Jun 30, 2026 | 167,768 | $3,266,443 | 0.0% | $7.4B |
Published ownership history
Historical positions are grouped by fund and accepted SEC portfolio snapshot.
| Fund | As of | Filing | Shares | Fair value | % of fund |
|---|---|---|---|---|---|
| T. Rowe Price Capital Appreciation Equity ETF | Jun 30, 2026 | NPORT-P | 167,768 | $3,266,443 | 0.0% |